In studies with recombinant factor VIII preparations, development of inhibitors is predominantly observed in previously untreated haemophiliacs.
En estudios con preparados de factor VIII de origen recombinante, el desarrollo de inhibidores se observa especialmente en pacientes hemofílicos no tratados previamente.